Elanco Animal Health Incorporated today announced U.S. Department of Agriculture (USDA) approval of TruCan™ Ultra B (Oral), an innovative oral vaccine designed to help protect dogs against Bordetella bronchiseptica, one of the primary pathogens associated with canine infectious respiratory disease…
Nicoya Life Sciences Expands Access to Gold-Standard SPR with Launch of Revo™ Platform Nicoya Life Sciences, Inc., a recognized leader in advanced biophysical characterization technologies for biologics discovery and development, has announced the launch of Revo™, a next-generation, label-free binding…
Niagen Bioscience, Inc. the global authority on NAD+ (nicotinamide adenine dinucleotide) science with a focus on healthy aging, today announced an expansion of consumer payment options for its flagship product, Tru Niagen, through a new partnership with Truemed. Through this…
MTF Biologics and Kolosis BIO Launch Summit Matrix™ to Advance Orthopedic and Spinal Surgery Outcomes MTF Biologics, a global nonprofit dedicated to saving and healing lives through tissue and organ donation, transplantation, and medical research, has partnered with Kolosis BIO…
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for Fibromyalgia Management Axsome Therapeutics, Inc. a biopharmaceutical company pioneering innovative treatments for central nervous system (CNS) disorders, announced today that the first patient has been dosed in the FORWARD Phase…
Orion Revamps Packaging to Boost Patient Experience and Sustainability Since 2020, Orion has been systematically reimagining its product packaging with a dual focus on patient safety and environmental sustainability. This ongoing effort has touched every stage of the supply chain—from…
Sobi Exceeds 2025 Revenue and Adjusted EBITA Margin Outlook Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced that its full-year 2025 revenue and adjusted EBITA margin have surpassed the company’s previous outlook, reflecting strong performance across its portfolio. Full-year…
Ipsen today announced the presentation of 14 scientific abstracts across a broad range of neurological conditions at TOXINS 2026, taking place from 14–17 January 2026 in Madrid. The presentations underscore Ipsen’s continued commitment to advancing evidence-based solutions and addressing persistent…
Sandoz Secures European Commission Approval for Ondibta® (Insulin Glargine), Reinforcing Leadership in Biosimilars and Diabetes Care Sandoz a global leader in affordable medicines, today announced that the European Commission has granted marketing authorization for Ondibta® (insulin glargine), a solution for…
Teva Pharmaceuticals Highlights AJOVY® Efficacy in Pediatric Migraine Following Publication in New England Journal of Medicine Teva Pharmaceuticals, the U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today that the New England Journal of Medicine (NEJM)…